Literature DB >> 20412755

Molecular targeting of islet autoantigens.

Brian Stadinski1, John Kappler, George S Eisenbarth.   

Abstract

Type 1 diabetes of man and animal models results from immune-mediated specific beta cell destruction. Multiple islet antigens are targets of autoimmunity and most of these are not beta cell specific. Immune responses to insulin appear to be essential for the development of diabetes of the NOD mouse. In this review, we will emphasize the unusual manner in which selected autoantigenic peptides (particularly the recently discovered target of BDC2.5 T cells [chromagranin A]) are presented and recognized by autoreactive CD4(+) T cell receptors. We hypothesize that "unusual" structural interactions of specific trimolecular complexes (MHC class II, peptide, and T cell receptors) are fundamental to the escape from the thymus of autoreactive T cells able to cause type 1 diabetes. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412755     DOI: 10.1016/j.immuni.2010.04.008

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  33 in total

1.  An update on the use of NOD mice to study autoimmune (Type 1) diabetes.

Authors:  Rodolfo José Chaparro; Teresa P Dilorenzo
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

2.  Novel autoantigens in type 1 diabetes.

Authors:  Shuhong Han; William Donelan; Hai Wang; Westley Reeves; Li-Jun Yang
Journal:  Am J Transl Res       Date:  2013-05-24       Impact factor: 4.060

Review 3.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 4.  T cell-driven initiation and propagation of autoimmune diabetes.

Authors:  Maria Bettini; Dario A A Vignali
Journal:  Curr Opin Immunol       Date:  2011-11-04       Impact factor: 7.486

5.  Glycemic Control, Cardiac Autoimmunity, and Long-Term Risk of Cardiovascular Disease in Type 1 Diabetes Mellitus.

Authors:  Giovane R Sousa; David Pober; Alfonso Galderisi; HuiJuan Lv; Liping Yu; Alexandre C Pereira; Alessandro Doria; Mikhail Kosiborod; Myra A Lipes
Journal:  Circulation       Date:  2019-02-05       Impact factor: 29.690

6.  Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.

Authors:  Li Zhang; Frances Crawford; Liping Yu; Aaron Michels; Maki Nakayama; Howard W Davidson; John W Kappler; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

7.  GAD autoantibody affinity in schoolchildren from the general population.

Authors:  Christine Bender; Michael Schlosser; Urs Christen; Anette G Ziegler; Peter Achenbach
Journal:  Diabetologia       Date:  2014-06-18       Impact factor: 10.122

Review 8.  Type 1 diabetes: translating mechanistic observations into effective clinical outcomes.

Authors:  Kevan C Herold; Dario A A Vignali; Anne Cooke; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

9.  Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets.

Authors:  Anna Moser; Hsiang-Ting Hsu; Peter van Endert
Journal:  F1000 Biol Rep       Date:  2010-10-21

10.  Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.

Authors:  Tarvo Rajasalu; Helen Brosi; Cornelia Schuster; Andreas Spyrantis; Bernhard Otto Boehm; Lieping Chen; Jörg Reimann; Reinhold Schirmbeck
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.